Cargando…
Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine
Since the initial emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1, several Omicron sublineages have emerged, leading to BA.5 as the current dominant sublineage. Here, we report the neutralization of different Omicron sublineages by human sera collected from ind...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647030/ https://www.ncbi.nlm.nih.gov/pubmed/36402138 http://dx.doi.org/10.1016/j.celrep.2022.111729 |
_version_ | 1784827295128616960 |
---|---|
author | Xie, Xuping Zou, Jing Kurhade, Chaitanya Liu, Mingru Ren, Ping Pei-Yong Shi |
author_facet | Xie, Xuping Zou, Jing Kurhade, Chaitanya Liu, Mingru Ren, Ping Pei-Yong Shi |
author_sort | Xie, Xuping |
collection | PubMed |
description | Since the initial emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1, several Omicron sublineages have emerged, leading to BA.5 as the current dominant sublineage. Here, we report the neutralization of different Omicron sublineages by human sera collected from individuals who had distinct mRNA vaccination and/or BA.1 infection. Four-dose-vaccine sera neutralize the original USA-WA1/2020, Omicron BA.1, BA.2, BA.2.12.1, BA.3, and BA.4/5 viruses with geometric mean titers (GMTs) of 1,554, 357, 236, 236, 165, and 95, respectively; two-dose-vaccine-plus-BA.1-infection sera exhibit GMTs of 2,114, 1,705, 730, 961, 813, and 274, respectively; and three-dose-vaccine-plus-BA.1-infection sera show GMTs of 2,962, 2,038, 983, 1,190, 1,019, and 297, respectively. Thus, the four-dose vaccine elicits the lowest neutralization against BA.5; the two-dose vaccine plus BA.1 infection elicits significantly higher GMTs against Omicron sublineages than the four-dose-vaccine; and the three-dose vaccine plus BA.1 infection elicits slightly higher GMTs (statistically insignificant) than the two-dose vaccine plus BA.1 infection. Finally, the BA.2.75 is more susceptible than BA.5 to four-dose-vaccine-elicited neutralization and three-dose-vaccine-plus-BA.1-infection-elicited neutralization. |
format | Online Article Text |
id | pubmed-9647030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author(s). |
record_format | MEDLINE/PubMed |
spelling | pubmed-96470302022-11-14 Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine Xie, Xuping Zou, Jing Kurhade, Chaitanya Liu, Mingru Ren, Ping Pei-Yong Shi Cell Rep Report Since the initial emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1, several Omicron sublineages have emerged, leading to BA.5 as the current dominant sublineage. Here, we report the neutralization of different Omicron sublineages by human sera collected from individuals who had distinct mRNA vaccination and/or BA.1 infection. Four-dose-vaccine sera neutralize the original USA-WA1/2020, Omicron BA.1, BA.2, BA.2.12.1, BA.3, and BA.4/5 viruses with geometric mean titers (GMTs) of 1,554, 357, 236, 236, 165, and 95, respectively; two-dose-vaccine-plus-BA.1-infection sera exhibit GMTs of 2,114, 1,705, 730, 961, 813, and 274, respectively; and three-dose-vaccine-plus-BA.1-infection sera show GMTs of 2,962, 2,038, 983, 1,190, 1,019, and 297, respectively. Thus, the four-dose vaccine elicits the lowest neutralization against BA.5; the two-dose vaccine plus BA.1 infection elicits significantly higher GMTs against Omicron sublineages than the four-dose-vaccine; and the three-dose vaccine plus BA.1 infection elicits slightly higher GMTs (statistically insignificant) than the two-dose vaccine plus BA.1 infection. Finally, the BA.2.75 is more susceptible than BA.5 to four-dose-vaccine-elicited neutralization and three-dose-vaccine-plus-BA.1-infection-elicited neutralization. The Author(s). 2022-11-29 2022-11-10 /pmc/articles/PMC9647030/ /pubmed/36402138 http://dx.doi.org/10.1016/j.celrep.2022.111729 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Report Xie, Xuping Zou, Jing Kurhade, Chaitanya Liu, Mingru Ren, Ping Pei-Yong Shi Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine |
title | Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine |
title_full | Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine |
title_fullStr | Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine |
title_full_unstemmed | Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine |
title_short | Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine |
title_sort | neutralization of sars-cov-2 omicron sublineages by 4 doses of the original mrna vaccine |
topic | Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647030/ https://www.ncbi.nlm.nih.gov/pubmed/36402138 http://dx.doi.org/10.1016/j.celrep.2022.111729 |
work_keys_str_mv | AT xiexuping neutralizationofsarscov2omicronsublineagesby4dosesoftheoriginalmrnavaccine AT zoujing neutralizationofsarscov2omicronsublineagesby4dosesoftheoriginalmrnavaccine AT kurhadechaitanya neutralizationofsarscov2omicronsublineagesby4dosesoftheoriginalmrnavaccine AT liumingru neutralizationofsarscov2omicronsublineagesby4dosesoftheoriginalmrnavaccine AT renping neutralizationofsarscov2omicronsublineagesby4dosesoftheoriginalmrnavaccine AT peiyongshi neutralizationofsarscov2omicronsublineagesby4dosesoftheoriginalmrnavaccine |